Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Decreases Holdings in Danaher Corporation (DHR)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. trimmed its position in shares of Danaher Corporation (NYSE:DHR) by 10.3% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,462 shares of the conglomerate’s stock after selling 10,471 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Danaher Corporation were worth $7,718,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in DHR. Peddock Capital Advisors LLC raised its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after acquiring an additional 181 shares in the last quarter. Proficio Capital Partners LLC raised its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after acquiring an additional 598 shares in the last quarter. ClariVest Asset Management LLC acquired a new stake in shares of Danaher Corporation in the first quarter valued at $157,000. Cornerstone Advisors Inc. raised its stake in shares of Danaher Corporation by 62.0% in the second quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock valued at $178,000 after acquiring an additional 808 shares in the last quarter. Finally, Baystate Wealth Management LLC raised its stake in shares of Danaher Corporation by 11.3% in the second quarter. Baystate Wealth Management LLC now owns 2,115 shares of the conglomerate’s stock valued at $181,000 after acquiring an additional 215 shares in the last quarter. Institutional investors own 75.68% of the company’s stock.

Danaher Corporation (NYSE DHR) opened at 88.11 on Tuesday. The company has a 50-day moving average price of $82.84 and a 200 day moving average price of $84.20. The stock has a market cap of $61.21 billion, a price-to-earnings ratio of 28.12 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.59.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same quarter in the previous year, the business posted $0.90 EPS. The firm’s revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts predict that Danaher Corporation will post $3.95 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.64%. Danaher Corporation’s dividend payout ratio is currently 17.83%.

TRADEMARK VIOLATION WARNING: “Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Decreases Holdings in Danaher Corporation (DHR)” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/09/19/mitsubishi-ufj-kokusai-asset-management-co-ltd-decreases-holdings-in-danaher-corporation-dhr.html.

DHR has been the topic of several analyst reports. Credit Suisse Group reiterated a “buy” rating and issued a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. Janney Montgomery Scott cut Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Thursday, June 15th. Zacks Investment Research cut Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. Finally, Deutsche Bank AG reiterated a “buy” rating and issued a $97.00 price objective on shares of Danaher Corporation in a research note on Wednesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Danaher Corporation currently has a consensus rating of “Buy” and an average target price of $92.72.

In other Danaher Corporation news, insider William King sold 7,458 shares of the business’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the transaction, the director now owns 42,151 shares in the company, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock worth $5,916,223 in the last quarter. 12.20% of the stock is currently owned by company insiders.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply